R speaks NLME (RsNLME) Page
RsNLME 为一套 R 程序包与 RShiny 应用程序的集合，使科研人员能够直接通过 R 命令行调用 Certara NLME 引擎运行模型。
Certara Acquires Integrated Nonclinical Development Solutions Blog Post
Expands software portfolio and nonclinical drug development expertise PRINCETON, N.J.— Jan 5, 2022– Certara, Inc., a global leader in biosimulation, today announced the acquisition of Integrated Nonclinical Development Solutions, Inc….
Exploring Changes in SDTMIG 3.4 & ADaMIG 1.3 Blog Post
On November 29th 2021, CDISC released updated versions of SDTM and ADaM, including standardized structures for medical devices and new non-compartmental analysis data. Moving to new versions of standards is...
A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease Blog Post
New therapeutics discovery and development for ocular diseases have been traditionally associated with a low probability of technical and regulatory success. The significant unmet medical needs for ocular diseases include…
Certara Announces Release of Pinnacle 21 Enterprise Software Blog Post
New metrics and analytics capabilities enable informed decision making for biopharmaceutical clients PRINCETON, N.J., Dec. 13, 2021 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced the…
Accelerating the establishment of precision medicine using PK-PD/TD modeling Blog Post
Certara’s Japan team first met Dr. Kobuchi when he was studying Pharmacometrics at university for his PhD. He frequently attended our software training courses to learn Phoenix software. His proactive…
Industry Metrics for CDISC Controlled Terminology Blog Post
Sergiy Sirichenko summarizes industry metrics across many studies and sponsors to produce an overall picture of CDISC Controlled Terminology utilization.
Developing Targeted Covalent Inhibitor Drugs: 3 Key Considerations Blog Post
传统的药物作用机制依赖于配体与其生物靶点之间可逆的、非共价的相互作用。另一方面，靶向共价抑制剂（TCI）药物的设计是为了...
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award Blog Post
Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category PRINCETON, NJ – 2021 年 10 月 25 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today…
